The Accipio Ix solution applies augmented machine learning to automatically analyze CT scan images. This accelerated image processing and computation flow enables physicians to prioritize patients when time is of the utmost importance. Working with Intel what typically takes Accipio 3-4 minutes to provide results is being driven to take less than 1 minute.
Accipio Ix has received both FDA clearance and CE Mark certification. In addition, MaxQ has partnerships with top CT and PACS companies including GE Healthcare, Samsung Neurologica and IBM Watson.
To learn more about MaxQ AI and the entire Accipio INSIGHT™ platform, visit www.maxq.ai, or follow the company on Twitter, and LinkedIn.
During RSNA 2018, MaxQ’s CEO Gene Saragnese participated in an Intel AI® sponsored panel. MaxQ will be participating in a similar discussion during the upcoming HIMSS19 conference, which is taking place February 11-15, 2019 in Orlando, Florida. More details to come.